{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03649",
    "Peptide Name": "N-[RLLR]3 (Arg-rich, Leu-rich; synthetic AMPs, UCLL1)",
    "Source": "de novo designed, man-made sequences",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "APKAMRLLRRLLRRLLR",
    "Sequence Length": 17,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 7,
    "Boman Index": 3.5,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "53%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals this sequence is most similar (60%) tosynthetic [RLLR]5R=L: 35%; A: 12%.  GRAVY: -0.25; M Wt: 2132.747; Mol formula: C94H178N36O18S1; molar extinction coeff: 0.Activity: active against Gram- E. coli (MIC 2 ug/ml), P. putida (MIC 4 ug/ml), S. enteritidis (MIC 2 ug/ml), Gram+  B. subtilis (MIC 2 ug/ml), S. aureus (MIC 2 ug/ml), S. mutans (MIC 4 ug/ml), fungi C. neoformans (MIC 2 ug/ml), S. cerevisiae (MIC 2 ug/ml), and C. albicans (MIC 1 ug/ml).Antimicrobial robustness: MIC increased 4-8 fold in the presence of 200 mM NaCL: NaCl-sensitive:E. coli; NaCl-sensitive:P. putida; NaCl-sensitive:S. enteritidis; NaCl-sensitive: B. subtilis; NaCl-sensitive:S. aureus; NaCl-sensitive:S. mutans; NaCl-sensitive:C. neoformans; NaCl-sensitive:S. cerevisiae;  NaCl-sensitive:C. albicans. Provided by Arjun Nair.",
    "Author": "Park IY, Cho JH, Kim KS, Kim YB, Kim MS, Kim SC. 2004",
    "Reference": "J Biol Chem. 2004 Apr 2;279(14):13896-901. doi: 10.1074/jbc.M311418200.Pub-Med.",
    "Title": "Helix stability confers salt resistance upon helical antimicrobial peptides."
  },
  "3D Structure": []
}